NF-κB expression in midbrain periaqueductal gray induced by electrical stimulation of dura near superior sagittal sinus in rats

Chinese Journal of Neurology

Volumn 40, Issue 11, 2007, Pages 771-774

  Wang, Rong Fei ^a   Yu, Sheng Yuan ^a   Liu, Ruo Zhuo ^a   Jiang, Lei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Dura mater; Electric stimulation; Migraine; NF kappa B; Periaqueductal gray

Indexed keywords

EID: 84860901201     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Grumont RJ, Gerondakis S. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med, 2000, 191: 1281-1292.
2. Chen F, Castranova V, Shi X, et al. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem, 1999, 45: 7-17.
3. Gugasyan R, Grumont R, Grossmann M, et al. Rel/NF-kappaB transcription factors: key mediators of B-cell activation. Immunol Rev, 2000, 176: 134-140.
4. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest, 2001, 107: 7-11.
5. Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest, 2001, 107: 3-6.
6. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest, 2001, 107: 7-11.
7. Pfaffenrath V, Diener HC, Fischer M, et al. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis: a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia, 2002, 22: 523-532.
8. Bowie A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol, 2000, 67: 508-514.
9. Groenewegen WA, Knight DW, Heptinstall S. Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit. J Pharm Pharmacol, 1986, 38: 709-712.
10. Reuter U, Chiarugi A, Bolay H, et al. Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol, 2002, 51: 507-516.
11. Raskin NH, Hosobuchi Y, Lamb S, et al. Headache may arise from perturbation of brain. Headache, 1987, 27: 416-420.
12. Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry, 1960, 23: 23-32.
13. 2003, 18: 10-13.